THe following anti-HIV drugs are known
to cause
“blood clotting problems”
Blood-clotting problems (Thrombocytopenia) is any disorder in which there are not enough platelets. Platelets are cells in the blood that help blood to clot. Thrombocytopenia can result in abnormal
bleeding and affects about 30 percent of all HIV patients who take HIV drugs.
Other “adverse drug reactions” (ADR) can include abdominal distension, dyspepsia, flatulence, gastro esophageal reflux disease, pancreatitis, influenza-like illness, malaise, hepatitis, hepatic failure, hyperbilirubinemia, cytolytic hepatitis, toxic hepatitis, hepatic steatosis, hypersensitivity, anorexia, decreased appetite, diabetes mellitus, facial wasting, hyperamylasemia, hypercholesterolemia, hyperglycemia, exanthem, lipoatrophy, lipodystrophy acquired, lipohypertrophy, pruritus, muscle cramps, dizziness, intracranial hemorrhage, somnolence, sleep disorder, renal insufficiency and can cause increases in hepatic enzymes, lipase and abnormal liver function.
Blood-clotting problems can result in massive intracranial hemorrhage (bleeding in the brain), often resulting in death. Intracranial hemorrhage accounts for 10-15% of all cases of stroke.
